J INTS BIO, a leader in oncology drug development, has announced interim preclinical results for its second-generation synthetic HSP90 inhibitor,…
We are committed to providing in-depth coverage of the latest news, trends, and events shaping the UK, ensuring you stay informed and up-to-date on the stories that matter most.
© EMC UK – emcuk.co.uk